Adimmune

• 2022-04-25

  Adimmune Supplies over 50% of Government QIV Procurement and Its International Sales Reaches New High

  Adimmune Corporation (4142) announced today the company is providing the Taiwan government with

• 2022-03-07

  Adimmune Predicts the WHO Recommended Seasonal Influenza Virus Strains

  Adimmune Corporation (TPE: 4142) announced today the company has precisely predicted WHO’s reco

• 2021-12-20

  Adimmune’s QIV and CDMO Global Marketing in Latin America, East Europe, Middle East, Southeast Asia, China

  Adimmune Corporation (TPE: 4142) announced its quadrivalent influenza vaccines have break into

• 2021-12-09

  Adimmune’s November Revenue Reflects 164% Growth

  Adimmune Corporation (TPE: 4142) today announced that its November revenue reached TWD210 milli

• 2021-11-22

  Adimmune Receives TWD 300M License Fee for COVID-19 Candidate Vaccine

  Adimmune Corporation (TPE: 4142) announced on 23rd that it has signed a Licensing Agreement for

• 2021-11-10

  Boosted by Global Orders, Adimmune Q3 Revenue Hits a New High

  Adimmune Corporation (TPE: 4142) announced on 10th the revenue of the third quarter (Q3). Benef

• 2021-10-07

  Adimmune Delivers Strong Q3 Revenue Growth, Driven by Influenza Vaccine

  Adimmune Corporation (TPE: 4142) announced on the 6th that the revenue for September 2021 reach

• 2021-09-23

  Adimmune to Supply Influenza Vaccine Antigen to Russia, Central Asia, and Eastern Europe

  Adimmune Corporation (TPE: 4142) announced on 22nd it has signed a contract with Petrovax, a Ru

• 2021-09-13

  Adimmune’s Next-Generation COVID-19 Vaccine Receives Clinical Trial Approval from Indonesia

  Adimmune Corporation (TPE: 4142) announced on the 13th its COVID-19 vaccine candidate has recei

• 2021-09-09

  Adimmune’s August Revenue Grows 40% with A Boost from New Production Line Launch

  Adimmune Corporation (TPE 4142) announced the revenue for August 2021 at TWD 236 million, a 40.

• 2021-08-12

  Adimmune’s new production line receives GMP certification, at the ready to manufacture public tender seasonal influenza vaccines

  Adimmune Corporation (4142) announced on the 11th that its second fill & finish line has pa

• 2021-07-08

  Adimmune announced a planned overseas manufacturing site in Indonesia, launching its global expansion

  Adimmune Corporation (4142) announced today that its first overseas manufacturing site will be

• 2021-05-25

  Onward to Southeast Asia, Adimmune Corporation and Innovalues signed MOU

  Adimmune Corporation (4142) announced on the 25th that Adimmune Corporation, Enimmune Corp., an

• 2021-04-07

  Adimmune Corporation successfully bid for the procurement of public tender seasonal influenza vaccines, continues its global market expansion

  Taiwan Centers for Disease Control (CDC) of Ministry of Health and Welfare announced today that

• 2021-03-02

  Adimmune Corporation precisely predicted the WHO recommended strains of seasonal influenza virus to ensure

  World Health Organization (WHO) announced in late February the recommended seasonal influenza v

• 2021-02-17

  Adimmune Corporation is developing the next generation of COVID-19 vaccines, commencing clinical trial overseas

  Adimmune Corporation (4142) announced that in response to the emerging variants of SARS-CoV-2 a

• 2021-01-20

  Adimmune Corporation and Korean Pharma signed an agreement for international collaboration on biosimila

  Adimmune Corporation (4142) announced the signing of an agreement with SCD, a leading ophthalmi

• 2020-12-30

  Adimmune Biotech Corporation(4142) is determined and committed to continue developing the COVID-19 vaccine

  Adimmune Biotech Corporation pointed out, after receiving the government's official notificatio

• 2020-12-29

  Prepared for the international markets Adimmune Biotech Corporation appointed Dr. Chun Cheng Chen as the Chief Medical Officer

  Adimmune Biotech Corporation(4142) announced today, beginning January 2021 Dr. Chun

• 2020-09-11

  Adimmune COVID-19 Vaccine Production Team Welcomes JHL Biotech, Inc

  Adimmune Biotech Corporation(4142) announced today that it has signed a Master Service Agreemen